Abstract: The present invention relates to compounds of formula (I). The compounds maybe used to antagonise the Stimulator of Interferon Genes (STING) protein and may thereby treat liver fibrosis, fatty liver disease, non-alcoholic steatohepatitis (NASH), pulmonary fibrosis, lupus, sepsis, rheumatoid arthritis (RA), type I diabetes, STING-associated vasculopathy with onset in infancy (SAVI), Aicardi-Goutieres syndrome (AGS), familial chilblain lupus (FCL), systemic lupus erythematosus (SLE), retinal vasculopathy, neuroinflammation, systemic inflammatory response syndrome, pancreatitis, cardiovascular disease, renal fibrosis, stroke and age- related macular degeneration (AMD).
| # | Name | Date |
|---|---|---|
| 1 | 202417007176-STATEMENT OF UNDERTAKING (FORM 3) [02-02-2024(online)].pdf | 2024-02-02 |
| 2 | 202417007176-PRIORITY DOCUMENTS [02-02-2024(online)].pdf | 2024-02-02 |
| 3 | 202417007176-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [02-02-2024(online)].pdf | 2024-02-02 |
| 4 | 202417007176-FORM 1 [02-02-2024(online)].pdf | 2024-02-02 |
| 5 | 202417007176-DECLARATION OF INVENTORSHIP (FORM 5) [02-02-2024(online)].pdf | 2024-02-02 |
| 6 | 202417007176-COMPLETE SPECIFICATION [02-02-2024(online)].pdf | 2024-02-02 |
| 7 | 202417007176-FORM-26 [18-03-2024(online)].pdf | 2024-03-18 |
| 8 | 202417007176-Proof of Right [26-03-2024(online)].pdf | 2024-03-26 |
| 9 | 202417007176-GPA-260324.pdf | 2024-04-15 |
| 10 | 202417007176-Correspondence-260324.pdf | 2024-04-15 |
| 11 | 202417007176-Others-280324.pdf | 2024-04-18 |
| 12 | 202417007176-Correspondence-280324.pdf | 2024-04-18 |
| 13 | 202417007176-FORM 3 [01-08-2024(online)].pdf | 2024-08-01 |
| 14 | 202417007176-RELEVANT DOCUMENTS [05-06-2025(online)].pdf | 2025-06-05 |
| 15 | 202417007176-MARKED COPIES OF AMENDEMENTS [05-06-2025(online)].pdf | 2025-06-05 |
| 16 | 202417007176-FORM 13 [05-06-2025(online)].pdf | 2025-06-05 |
| 17 | 202417007176-AMMENDED DOCUMENTS [05-06-2025(online)].pdf | 2025-06-05 |
| 18 | 202417007176-FORM 18 [06-06-2025(online)].pdf | 2025-06-06 |